X
ALMS

Xponance’s Alumis Inc ALMS Stock Holding History

Xponance’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+7,751
New +$180K ﹤0.01% 1568

Other funds holding ALMS

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Xponance's ALMS Position: Q2 2026 in Review

Xponance opened a new position in Alumis Inc (ALMS) in Q2 2026: 7,751 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1568 among its holdings.

199 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

  • Xponance held 7,751 shares of Alumis Inc worth $218K as of Q2 2026.
  • Alumis Inc was a new Xponance position in Q2 2026.
  • Alumis Inc made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1568 holding.
  • 199 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.